Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex

British Journal of Pharmacology

Volumn 138, Issue 2, 2003, Pages 317-324

  Storer, R J ^a   Akerman, S ^a   Goadsby, P J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Craniovascular; Headache; Microiontophoresis; Migraine; Nociception; Opioid; Trigeminal nucleus caudalis

Indexed keywords

CHLORALOSE; CHLORIDE ION; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLARGINYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GLUTAMIC ACID; HALOTHANE; MU OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR ANTAGONIST; OPIATE AGONIST; OPIATE RECEPTOR; SODIUM ION;

ANIMAL EXPERIMENT; ARTICLE; CAT; CONTROLLED STUDY; DOSE RESPONSE; DRUG SELECTIVITY; ELECTROSTIMULATION; EVOKED RESPONSE; HEADACHE; IONTOPHORESIS; MIGRAINE; NEUROMODULATION; NEUROTRANSMISSION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SUPERIOR SAGITTAL SINUS; SYNAPSE; TRIGEMINAL NERVE;

ANIMALS; CATS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; NEURAL PATHWAYS; PAIN MEASUREMENT; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU; SUPERIOR CERVICAL GANGLION; TRIGEMINAL NUCLEI;

EID: 0037278370     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0705034     Document Type: Article

References (63)

1. BAHRA, A., MATHARU, M.S., BUCHEL, C., FRACKOWIAK, R.S.J. & GOADSBY, P.J. (2001). Brainstem activation specific to migraine headache. Lancet, 357, 1016-1017.
2. 1) receptor ligand nociceptin (NCE/orphanin FQ) inhibits trigeminovascular activation in the meningeal circulation of the rat. Cephalalgia, 22, 572.
3. BEREITER, D.A. (1997). Morphine and somatostatin analogue reducc c-FOS expression in trigeminal subnucleus caudalis produced by corneal stimulation in the rat. Neuroscience, 77, 863-874.
4. BLOOM, F.E. (1974). To spritz or not to spritz: the doubtful value of aimless iontophoresis. Life Sci., 14, 1819-1834.
5. BOVILL, J.G. (1997). Mechanisms of actions of opioids and non-steroidal anti-inflammatory drugs. Eur. J. Anaesthesiol., 15, 9-16.
6. CHIENG, B., CONNOR, M. & CHRISTIE, M.J. (1996). The mu-opioid receptor antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) [but not D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP)] produces a nonopioid receptor-mediated increase in K+ conductance of rat locus ceruleus neurons. Mol. Pharmacol., 50, 650-655.
7. CLASSEY, J.D., KNIGHT, Y.E. & GOADSBY, P.J. (2001). The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res., 907, 117-124.
8. COX, B.M. (2000). Opioid receptors. In The Compendium of Receptor Characterization and Classification. pp. 321-333. London: IUPHAR Media.
9. DE VRIES, P., VILLALON, C.M. & SAXENA, P.R. (1999). Pharmacological aspects of experimental headache models in relation to acute antimigraine therapy. Eur. J. Pharmacol., 375, 61-74.
10. EDVINSSON, L. (1999). Experimental Headache Models in Animals and Man. London: Martin Dunitz.
11. FEINDEL, W., PENFIELD, W. & MCNAUGHTON, F. (1960). The tentorial nerves and localization of intracranial pain in man. Neurology, 10, 555-563.
12. FUSSEY, I.F., KIDD, C. & WHITWAM, J.G. (1970). The differentiation of axonal and soma-dendritic spike activity. Pflügers Arch., 321, 283-292.
13. GOADSBY, P.J. (2000). The pharmacology of headache. Prog. Neurobiol., 62, 509-525.
14. GOADSBY, P.J. (2002). Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol., 1, 37-43.
15. 1) receptors in the trigeminocervical complex. Ann. Neurol., 50, 804-807.
16. GOADSBY, P.J. & CLASSEY, J.D. (2000). Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res., 875, 119-124.
17. GOADSBY, P.J., EDVINSSON, L. & EKMAN, R. (1990). Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann. Neurol., 28, 183-187.
18. GOADSBY, P.J. & HOSKIN, K.L. (1997). The distribution of trigeminovascular afferents in the non-human primate brain Macaca nemestrina: a c-fos immunocytochemical study. J. Anat., 190, 367-375.
19. GOADSBY, P.J., LIPTON, R.B. & FERRARI, M.D. (2002). Migraine - current understanding and treatment. N. Engl. J. Med., 346, 257-270.
20. GOADSBY, P.J. & ZAGAMI, A.S. (1991). Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. Brain, 114, 1001-1011.
21. GOWERS, W.R. (1888). A Manual of Diseases of the Nervous System. London: J&A Churchill.
22. GULYA, K., PELTON, J.T., HRUBY, V.J. & YAMAMURA, H.I. (1986). Cyclic somatostatin octapeptide analogues with high affinity and selectivity toward mu opioid receptors. Life Sci., 38, 2221-2229.
23. HELLIER, M., BOERS, P & LAMBERT, G.A. (1990). Fabrication of a metal-cored multi-barrelled microiontophoresis assembly. J. Neurosci. Meth., 32, 55-61.
24. HENRY, J.L., SESSLE, B.J., LUCIER, G.E. & HU, J.W. (1980). Effects of substance P on nociceptive and non-nociceptive trigeminal brain stem neurons. Pain, 8, 33-45.
25. HOSKIN, K.L., KAUBE, H. & GOADSBY, P.J. (1996). Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiology study. Brain, 119, 249-256.
26. HU, J.W., DOSTROVSKY, J.O. & SESSLE, B.J. (1981). Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis. J. Neurophysiol., 45, 173-192.
27. KAUBE, H., KEAY, K.A., HOSKIN, K.L., BANDLER, R. & GOADSBY, P.J. (1993). Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical cord following stimulation of the superior sagittal sinus in the cat. Brain Res., 629, 95-102.
28. KRAMER, T.H., SHOOK, J.E., KAZMIERSKI, W., AYRES, E.A., WIRE, W.S., HRUBY, V.J. & BURKS, T.F. (1989). Novel peptidic mu opioid antagonists: pharmacologic characterization in vitro and in vivo. J. Pharmacol. Exp. Ther., 249, 544-551.
29. LAMBERT, G.A., LOWY, A.J., BOERS, P., ANGUS-LEPPAN, H. & ZAGAMI, A. (1992). The spinal cord processing of input from the superior sagittal sinus: pathway and modulation of ergot alkaloids. Brain Res., 597, 321-330.
30. MCNAUGHTON, F.L. & FEINDEL, W.H. (1977). Innervation of intracranial structures: a reappraisal. In Physiological aspects of Clinical Neurology. ed. Rose, F.C. pp. 279-293. Oxford: Blackwell Scientific Publications.
31. MENKEN, M., MUNSAT, T.L. & TOOLE, J.F. (2000). The global burden of disease study - implications for neurology. Arch. Neurol., 57, 418-420.
32. MITSIKOSTAS, D.D., SANCHEZ DEL RIO, M., WAEBER, C., HUANG, Z., CUTRER, F.M. & MOSKOWITZ, M.A. (1999). Non-NMDA glutamate receptors modulate capsaicin induced c-fos expression within trigeminal nucleus caudalis. Br. J. Pharmacol., 127, 623-630.
33. MITSIKOSTAS, D.D., SANCHEZ DEL RIO, M., WAEBER, C., MOSKOWITZ, M.A. & CUTRER, F.M. (1998). The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis. Pain, 76, 239-248.
34. MOGIL, J.S. & PASTERNAK, G.W. (2001). The molecular and behavioral pharmacology of the orphanin FQ/nociceptin peptide and receptor family. Pharmacol. Rev., 53, 381-415.
35. NAPPI, G., FACCHINETTI, F., MARTIGNONI, E., PETRAGLIA, F., MANZONI, G.C., SANCES, G., SANDRINI, G. & GENAZZANI, A.R. (1985). Endorphin patterns within the headache spectrum disorders. Cephalalgia, 5, 201-210.
36. 2+ channel gene CACNL1A4. Cell, 87, 543-552.
37. PASTERNAK, G.W. (1993). Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol., 16, 1-18.
38. PELTON, J.T., KAZMIERSKI, W., GULYA, K., YAMAMURA, H.I. & HRUBY, V.J. (1986). Design and synthesis of conformationally constrained somatostatin analogues with high potency and specificity for μ opioid receptors. J. Med. Chem., 29, 2370-2375.
39. PIROS, E.T., HALES, T.G. & EVANS, C.J. (1996). Functional analysis of cloned opioid receptors in transfected cell lines. Neurochem. Res., 21, 1277-1285.
40. RASMUSSEN, B.K. (1995). Epidemology of headache. Cephalalgia, 15, 45-68.
41. RAYNOR, K., KONG, H., CHEN, Y., YASUDA, K., YU, L., BELL, G.I. & REISINE, T. (1994). Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol., 45, 330-334.
42. REISINE, T. & PASTERNAK, G. (1996). Opioid analgesics and antagonists. In The Pharmacological Basis of Therapeutics. ed. Hardman, J.G., Limbird, L.E., Molinoff, P.B., Ruddon, R.W. & Gilman, A.G. pp. 521-556. New York: McGraw-Hill.
43. RHIM, H. & MILLER, R.J. (1994). Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J. Neurosci., 14, 7608-7615.
44. RUSSELL, M.B. & OLESEN, J. (1995). Increased familial risk and evidence of genetic factor in migraine. BMJ, 311, 541-544.
45. SCHINDLER, M., HOLLOWAY, S., HATHWAY, G., WOOLF, C.J., HUMPHREY, P.P. & EMSOM, P.C. (1998). Identification of somatostatin sst2(a) receptor expressing neurones in central regions involved in nociception. Brain Res., 798, 25-35.
46. SCHROEDER, J.E., FISCHBACH, P.S., ZHENG, D & MCCLESKEY, E.W. (1991). Activation of mu opioid receptors inhibits transient high- and low-threshold Ca2+ currents, but spares a sustained current. Neuron, 6, 13-20.
47. SILBERSTEIN, S.D. & MCCRORY, D.C. (2000). Opioids. Cephalalgia, 20, 854-864.
48. STORER, R.J., AKERMAN, S. & GOADSBY, P.J. (2001). Opioid receptors modulate nociceptive neurotransmission in the trigeminocervical complex. Cephalalgia, 21, 354.
49. STORER, R.J., BUTLER, P., HOSKIN, K.L. & GOADSBY, P.J. (1997). A simple method, using 2-hydroxypropyl-β-cyclodextrin, of administering α-chloralose at room temperature. J. Neurosci. Meth., 77, 49-53.
50. 1B/1D agonists inhibits trigeminal cell firing in the cat. Brain, 120, 2171-2177.
51. STORER, R.J. & GOADSBY, P.J. (1999). Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience, 90, 1371-1376.
52. SUH, H.H. & TSENG, L.F. (1990). Different types of opioid receptors mediating analgesia induced by morphine, DAMGO, DPDPE, DADLE and beta-endorphin in mice. Naunyn Schmiedebergs Arch. Pharmacol., 342, 67-71.
53. WANG, X.-M. & MOKHA, S.S. (1996). Opioids modulate N-methyl-D-aspartic acid (NMDA)-evoked responses of trigeminothalamic neurons. J. Neurophysiol., 76, 2093-2096.
54. WANG, X.-M., ZHANG, K.M., LONG, L.O., FLORES, C.A. & MOKHA, S.S. (2000). Endomorphin-1 and endomorphin-2 modulate responses of trigeminal neurons evoked by N-methyl-D-aspartic acid and somatosensory stimuli. J. Neurophysiol., 83, 3570-3574.
55. WEILLER, C., MAY, A., LIMMROTH, V., JUPTNER, M., KAUBE, H., SCHAYCK, R.V., COENEN, H.H. & DIENER, H.C. (1995). Brain stem activation in spontaneous human migraine attacks. Nat. Med., 1, 658-660.
56. WILLIAMSON, D.J., HARGREAVES, R.J., HILL, R.G. & SHEPHEARD, S.L. (1997a). Sumatriptan inhibits neurogenic vasodilation of dural blood vessels in the anaesthetized rat-intravital microscope studies. Cephalalgia, 17, 525-531.
57. 1B/1D agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guineapigs. Br. J. Pharmacol., 133, 1029-1034.
58. WILLIAMSON, D.J., SHEPHEARD, S.L., COOK, D.A., HARGREAVES, R.J., HILL, R.G. & CUMBERBATCH, M.J. (2001b). Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized rats. Br. J. Pharmacol., 133, 807-814.
59. WILLIAMSON, D.J., SHEPHEARD, S.L., HILL, R.G. & HARGREAVES, R.J. (1997b). The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation. Eur. J. Pharmacol., 328, 61-64.
60. WOLFF, H.G. (1948). Headache and Other Head Pain. New York: Oxford University Press.
61. WONG, C.L., CHAN, Y.S., CHEUNG, Y.M., HWANG. J.C., POON, P.W. & WONG, T.M. (1986). Effects of superfusion of morphine and enkephalins on the activity of single units in the spinal trigeminal nucleus and cuneate nucleus of cat. Methods Find. Exp. Clin. Pharmacol., 8, 351-355.
62. ZHANG, K.-M., WANG, X.-M. & MOKHA, S.S. (1996). Opioids modutate N-methyl-D-aspartic acid (NMDA)-evoked responses of neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis). Brain Res., 719, 229-233.
63. ZIEGLER, D.K. (1997). Opioids in headache treatment. Is there a role? In Neurol. Clin. North Am. ed. Mathew, N.T. pp. 199-207. Philadelphia: WB Saunders.